• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • Twitter

International Alliance of ALS/MND Associations

  • Members’ Login
  • Contact
  • Join
  • Donate
  • What is ALS/MND?
  • Events
    • Alliance Meeting 2021
    • Allied Professionals Forum 2021
    • ALS/MND Connect 2020
    • International Symposium on ALS/MND 2020
    • Awards
    • Webinars
  • March of Faces
  • Find an Association
  • Support for Members
    • Partnership Programme
    • Mentorship Programme
    • Alliance Support Grant
  • Advocacy
    • Advocacy Toolkit
    • Rights of People with ALS/MND
    • Biogen – Tofersen
    • BrainStorm Cell Therapeutics – NurOwn
    • Collaborative Medicinal Development – CuATSM
    • Cytokinetics – Reldasemtiv
    • Right to Try
    • Unproven (Off-Label) Treatments
    • US FDA Orphan Drug Designation
    • T Regulatory Cell Therapies
    • Amylyx – AMX0035
    • Kadimastem – AstroRx
  • Global Day
  • Resources
    • Submit a Resource
  • Newsletters
  • About
    • About the Alliance
    • Newsletter subscription
    • Board of Directors
    • Committees/Advisory Councils
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Governance Committee
      • Budget and Finance Committee
    • Staff
    • History

Click here for Coronavirus (COVID-19) updates

Dutch

Wat Is ALS? Copy

February 28, 2018 by

Amyotrofische Laterale Sclerose (ALS) is een dodelijke zenuw-spierziekte die alle spiergroepen, met uitzondering van de autonoom aangestuurde spieren, kan aantasten. Een ALS-patiënt overlijdt gemiddeld 33 maand na de diagnose door verlamming van de ademhalings- of slikspieren. Er is echter een aanzienlijke spreiding in de uiteindelijke levensverwachting van ALS-patiënten.

Wat is ALS?

February 27, 2018 by

Amyotrofische Laterale Sclerose (ALS) is één van de meest ernstige en invaliderende aandoeningen van het zenuwstelsel. Nederland telt op dit moment ongeveer 1500 patiënten. Gemiddeld overlijden er elk jaar 500 patiënten en komen er 500 bij.

ALS Centrum Nederland

February 27, 2018 by

The national centre for ALS research, information and treatment in the Netherlands.

Primary Sidebar

Back to resources

Allied Professionals Forum Registration

The International Alliance of ALS/MND Associations will host a virtual Allied Professionals Forum spread over two days to accommodate time zones on 3 – 4 December 2020.

Click here to register for the Allied Professionals Forum

Footer

Support the Alliance

Please donate

Please consider making a donation to support our work. Thank you!

Latest Tweets

  • Our friends from @MND_RIA @KingsCollegeLon @BostonChildrens may want to tune in to hear @CEBirks @AmmarAlChalabi an… https://t.co/gu8X4gTfC8 Yesterday at 8:08 pm
  • Join us on March 4th for the Alliance's first Webinar of 2021: "Sharing Success: Fireside Chat with Award Winners" - https://t.co/PrfTYt1Q5Z Yesterday at 4:59 pm
  • The International Society for Frontotemporal Dementias is hosting their International Conference next week March 3-… https://t.co/ZhyToPGr2U Yesterday at 2:20 pm

Keep in touch

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

Return to top of page
  • Disclaimer
  • Privacy notice & Cookies
  • Sitemap

Copyright © 2021 The International Alliance of ALS/MND Associations. All rights reserved.

Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login